PT  - JOURNAL ARTICLE
AU  - Xiuying Guo
AU  - Zhi Guo
AU  - Haipeng Yu
AU  - Fang Liu
AU  - Junyi Zhang
AU  - Jizhong Xing
TI  - TACE Combined with PSE in Treating Hepatocelluar Carcinoma with Hypersplenism
DP  - 2005 Jun 01
TA  - Chinese Journal of Clinical Oncology
PG  - 627--630
VI  - 2
IP  - 3
4099  - http://www.cancerbiomed.org/content/2/3/627.short
4100  - http://www.cancerbiomed.org/content/2/3/627.full
SO  - Cancer Biol Med2005 Jun 01; 2
AB  - OBJECTIVE To observe the effectiveness and safety of transcatheter arterial chemoembolization (TACE) combined with partial splenic embolization (PSE) in treating primary hepatocelluar carcinoma (HCC) with hypersplenism.METHODS Thirty HCC patients with liver cirrhosis, portal hypertension and hypersplenism were treated with TACE and PSE. The degree of tumor volume reduction and remission of hypersplenism were observed.RESULTS The tumor reduction rate of the HCC was 73.3%. Twenty-eight patients had hypersplenic remission with a rate of 93.3%. There were no severe complications such as hepatic abscesses.CONCLUSION TACE combined with PSE is a safe and effective method to treat HCC with liver cirrhosis, portal hypertension and hypersplenism.